Trading and Settlement of Trades in Dematerialised Securities
Trading Members are hereby informed that Sarda Proteins Ltd. (scrip code: 519242) has signed the agreement with both the Depositories.
In this regard, the modalities for settlement of trades executed in the scrip of the Company w.e.f. Friday, February 16, 2018 (Sett. No. DR-221/2017-2018) would be as follows:
- The scrip would continue to be traded in Trade to Trade Segment for reasons other than non-signing of agreements with depositories. However the trades in scrip would be required to be settled in compulsory demat form.
- All trades executed in the scrip would be in market lot of 1 equity share
- Netting will not be allowed in the scrip.
- Shortages in the scrip would be directly closed-out.
Trading Members are also requested to note the revised Group & Market Lot of the security of the Company as follows:
|
Sr.
|
Scrip Code
|
Scrip Name
|
Current Group
|
Revised Group
|
Current Market Lot
|
Revised Market Lot
|
|
1
|
519242
|
Sarda Proteins Ltd.
|
P
|
XT
|
100
|
1
|
In case of any query / clarification, Trading Members may please contact :
|
Sr. No.
|
Name of the Officer
|
Telephone No
|
|
1
|
Mr. Marian Dsouza
|
022-2272 8744
|
|
2
|
Mr. Amol Hosalkar
|
022 -2272 8390
|
Mangesh Tayde
Senior Manager
022 – 2272 8846 |